Clinical Catalysts And Roche Alliance Will Advance Obesity Amid Risks
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 15 Analysts
Published
17 Aug 25
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
DKK 835.47
51.1% undervalued intrinsic discount20 Aug
DKK 408.50
1Y
-53.3%7D
19.8%